The Use of Oestrogens in Obstetrics and Gynaecology
Total Page:16
File Type:pdf, Size:1020Kb
THE USE OF OESTROGENS IN OBSTETRICS AND GYNAECOLOGY by A. I. S. LACPHERSON , Iú..B., Ch.B. Essay submitted for the Gunning Victoria Jubilee Prize, 1940. The term oestrogen is applied to substances which are characterised by a capacity to restore oestrus or heat in the castrate female animal. The pioneer work of Allen and Doisy (1923), is a landmark in the development of sex endocrinology. By using the vaginal smear which Stockard and Papanicolaou (1917) had shown to undergo definite and constant variations in relation to the separate phases of the oestrus cycle, they demonstrated that a substance could be extracted from the ovary which, when injected into castrate rodents, was active in bringing on heat. No progress was made in the isolation of this substance until it was found that large quantities were excreted in the urine of pregnant animals (Ascheim and Zondek, 1927). The crystallisation of the substance (Butendandt, 1929; Doisy et al., 1929: Larrian, 1929) was early followed by demonstration of its relation to the sterols - one of the most important biochemical groups in normal and abnormal metabolism - and eventually five naturally occurring oestrogens were isolated from the ovary, pregnancy urine and the placenta, all with an identical basic formula (1) and a similar qualitative action cm3 ON C=C SO Ho 3- 2. Of these three are used clinically, viz. Oestradiol (dihydroxyoestrin), Oestrone (ketohydroxyoestrin) and Oestriol (trihydroxyoestrin). That in most common usage to -day is the esterified form of oestradiol known as oestradiol benzoate. STANDARDISATION. Until 1935, standardisation was entirely by biological tests, and, as the criteria adopted by each worker varied, it was impossible to correlate results from different preparations and complete chaos reigned. The Committee on Hormones of the League of Nations Permanent Health Commission laid down as the International Unit for Oestrone the activity of 0.1y, (- .0001mg.) of a standard preparation, and later fixed the International Benzoate Unit (I. B. U.) as the activity of O.1,/of a standard preparation of oestradiol benzoate. By relating the standard to a definite weight of a chemically pure substance the Committee placed Oestrogens on a similar footing to many drugs in the Pharmacopeia, and it is therefore only fitting that oestrogens should be prescribed in milligrams, and not in astronomical numbers of biological units. SYNTHETIC OESTROGENS. It was thought until recently that the cyclo -penteno- phenantlirene nucleus was an essential part of any oestrogenic substance. workers in London and Cambridge (Dodds and Lawson, 1936: Dodds et al., 1938 / 3. 1938 a and b) have ho ever succeeded in synthesizing a surprisingly simple series of compounds which culminated in the production of 4 : 4_ dihydroxy d -0 diethylstilbene (stilboestrol) (2 ),and its derivative dihydrostilboestrol (Hexoestrol). workers in Edinburgh have developed another synthetic compound, triphenylchlorethylene (3) (Robson and Schönberg, 1937). These synthetic compounds have been shown to have an oestrogenic action similar to the naturally occurring oestrogens (Dodds et al., 1938 b: Robson, 1938) and to be highly active orally. It is possible that they are products of the metabolism of oestradiol and have an initial immunity to break- down by the liver. (Shore et al., 1939). ADMINISTRATION. All oestrogenic substances may be given orally, by injection, and locally through mucous membranes. The natural oestrogens are also effective percutaneously provided an organic solvent such as alcohol or benzol is used (Zondek, B., 1938). On oral administration the synthetic oestrogens are all highly active, whereas the ratio of potency by mouth and by injection of pure natural oestrogen is 1:500 (Inhoffen et al., 1938). There is little difference in the duration of action by mouth of the same large dose of oestradiol, oestradiol benzoate, stilboestrol and triphenylchlorethylene (Robson, Schönberg and Fahim, 1938). By injection, speed and duration of action / 4. action depend upon the method emplòyed. Short and concentrated action may be obtained by giving a large number of small doses of the natural hormone in aqueous solution. The substance in this case is rapidly absorbed and rapidly broken down by the body. Slower and more prolonged action results from injection of the oestrogen in an oily solution, and this can be enhanced by injecting the esterified substance, e.g. oestradiol benzoate. Triphenylchlorethylene is characterised by a singularly prolonged action when injected in an oily solution - in animals a demonstrable effect is presont for nearly 20 weeks (Robson, Schönberg and Fahim, 1938), and in man effects have been seen 6 - 9 weeks after two subcutaneous injections at weekly intervals of 250mg. (Macpherson and Robertson, 1939). It is apparent that the absolute activities of the natural and synthetic oestrogens are dependent upon threshold activity, duration of action and intensity of action (Liescher, Scholz and Tschopp, 1938). Consequently, accurate comparison between them for clinical usage is difficult. Oestradiol benzoate by injection and stilboestrol orally have a corresponding threshold activity and approximately the same duration of action, i e. dosage will be similar and will amount to a very few milligrams. The threshold activity of triphenylchlorethylene is approximately 1/10,000 that of oestradiol, but its action is so concentrated and, by injection, so much more prolonged (Robson, 1938) that dosage is not higher in proportion to the difference in threshold / threshold activity. Three points must be borne in mind for successful oestrogenic therapy. .eirstly, the substances do not act instantaneously. Even with frequent small injections of aqueous solution, maximal action does not occur for about 24 - 48 hours, and after administration of an oily solution or by mouth, the latent period is longer than this, probably at least three days. Consequently, where oestrogens are given to make up a deficiency or as an antagonist to another hormone, full clinical effects should not be expected under these times. Secondly, prolonged and continuous treatment will result not only in deleterious local effects in the uterus and breasts, but to some extent in pituitary and hence in ovarian inhibition. dhere prole nged treatment is contemplated, therefore, it should be arranged "in courses ", so that there is an interval during which the organism is subjected to a progressively decreasing quantity of circulating oestrogen, a condition similar to the normal cyclical activity of the follicular hormone. Thirdly, the effects of oestrogen administration are transient, and when the circulating blood oestrin falls below the level of endometrial stimulation, bleeding will occur from the uterus. l.his oestrin withdrawal bleeding appears 5 - 12 days after the cessation or reduction of treatment and can be controA.ed by further oestrogen administration. PHYSIOLOGY / 6. PHYSIOLOGY. The natural ovarian follicular secretion is responsible for the growth and adult development of the secondary sexual apparatus - uterus, vagina and breasts, It is essential for proliferation of the endometrium during the first part of the menstrual cycle and, in its absence, progesterone is unable to induce the secretory changes characteristic of the progestational phase of the cycle. It increases the vascularity and hence the size, and the metabolism of the uterus. Under its influence, both the spontaneous activity and the reactivity of the muscle to the oxytocic principle of the posterior pituitary lobe are increased. It causes cornification of the vagina and increases the cervix. In the breast, it is concerned in the growth of the ductular system and acts with the luteal hormone in stimulating alveolar development (Nelson, 1936). It appears to be antagonistic to, or at any rate to have an inhibitory effect upon the gonadotrophic (Rowlands and Sharpey Schafer, 1940), and lactogenic principles of the anterior pituitary (Nelson, 1936). OVARIAN DEFICIENCY. Clinical usage is rationally determined by the deficiency of some or any ofthese functions. Diminished ovarian secretion commonly leads to the symptoms included under the term "menopausal ". In the menopausal syndrome, disturbances of the autonomic nervous system / 7. system, of such a character as to.- suggest a sympathetic irritability and a parasympathetic depression (Donald, 1937), are outstanding - hot flushes, sweatings, palpitations, tachycardia, coldness of the extremities, migrainous headaches, true menopausal hypertension, urinary sphincteric irritability, obesity - but other neurogenic symptoms of more uncertain origin also occur, for example insomnia, vertigo, emotional instability amounting even to a paranoid psychosis (Strachan and Skottowe, 1933). Amenorrhoea, oligomenorrhoea, frigidity, and varying degrees of atrophy or of failure of development of the secondary sex organs are the characteristic genital symptoms of ovarian deficiency, and certain general effects may also occur - menopausal arthritis, especially of the metacarpal joints (Hanne, 1937) fibrositis, hyperthyroidism, allergic manifestations arising apparently de novo (Donald, 1937), hirsutism, possibly a suprarenal cortical phenomenon (Zondek, H.,1935), and other skin changes. In relation to the syndrome described as menopausal, it is important to notice that a symptomless cessation of the menses ( "menopause ") may be followed some years later by "menopausal" (true "climacteric ") symptoms (Bishop, 1937 b: Donald,